Gilead Sciences Announces 11 Percent Increase in First Quarter 2019 Dividend
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 11% in the company’s quarterly cash dividend, beginning in the first quarter of 2019. The increase will result in a quarterly dividend of $0.63 per share of common stock. The dividend is payable on March 28, 2019, to stockholders of record at the close of business on March 15, 2019. Future dividends will be subject to Board approval.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-MOBILEIRON22.8.2019 09:02:07 CEST | Press release
MobileIron Named a Leader Again in the Second Gartner Magic Quadrant for Unified Endpoint Management Tools
MIRACOR-MEDICAL22.8.2019 08:02:07 CEST | Press release
Miracor Medical Granted FDA Breakthrough Device Designation for the PiCSO Impulse System
MORI-BUILDING22.8.2019 06:02:06 CEST | Press release
Mori Building Unveils Massive Urban Regeneration Project in Central Tokyo
MUNDIPHARMA22.8.2019 01:03:13 CEST | Press release
Mundipharma Announces the Licence Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medicines Agency
NY-TRITON-DIGITAL21.8.2019 22:02:07 CEST | Press release
Triton Digital Releases Webcast Metrics Rankings for the Top Digital Audio Properties for April 2019
CELSIUS-NETWORK21.8.2019 17:17:05 CEST | Press release
Celsius Partners With Tether to Bring USDT its Highest Interest-earning Wallet at 10.53% APR
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom